Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Exclusion Criteria5

• Patients with cardiogenic shock at the time of hospitalization
• Patients who are pregnant or planning to become pregnant
• Patients with a life expectancy of less than 1 year
• Patients participating in randomized controlled trials using other medical devices
• Patients who have already received treatment with another DES (Drug Eluting Stent) or BMS (Bare Metal Stent) at the time of registration (However, other stent insertions are allowed due to failure of GENOSS DES insertion)